Characterization of Cerebellum-Specific Ribosomal DNA Epigenetic Modifications in Alzheimer's Disease: Should the Cerebellum Serve as a Control Tissue After All?

Author(s):Show less -

Faria, Tathyane C. ^[1] ; Maldonado, Hector L. ^[2] ; Santos, Leonardo C. ^[1] ; DeLabio, Roger ^[3] ; Payao, Spencer L. M. ^[3] ; Turecki, Gustavo ^[4] ; Mechawar, Naguib ^[4] ; Santana, Dalileia A. ^[1] ; Gigek, Carolina O. ^[1] ; Lemos, Bernardo ^{[2, 5]} ; Smith, Marilia A. C. ^[1] ; Chen, Elizabeth S. ^{[1, 2]}

Affiliation

^[1] Univ Fed Sao Paulo UNIFESP EPM, Dept Morfol & Genet, Programa Posgrad Biol Estrutural & Func UNIFESP E, Disciplina Genet, Sao Paulo, SP - Brazil

^[2] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 - USA

^[3] Fac Med Marilia FAMEMA, Marilia, SP - Brazil

^[4] McGill Univ, Douglas Hosp, Res Ctr, Dept Psychiat, Montreal, PQ - Canada

^[5] Broad Inst Harvard & MIT, Cambridge, MA - USA

• Document type: Journal article
• Source: Molecular Neurobiology; v. 57, n. 6 MAR 2020.
• Web of Science Citations: 0

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease, known as the most common form of dementia. In AD onset, abnormal rRNA expression has been reported to be linked in pathogenesis. Although region-specific expression patterns have previously been reported in AD, it is not until recently that the cerebellum has come under the spotlight. Specifically, it is unclear whether DNA methylation is the mechanism involved in rRNA expression regulation in AD. Hence, we sought to explore the rDNA methylation pattern of two different brain regions - auditory cortex and cerebellum - from AD and age-/sex-matched controls. Our results showed differential hypermethylation at an upstream CpG region to the rDNA promoter when comparing cerebellum controls to auditory cortex controls. This suggests a possible regulatory region from rDNA expression regulation. Moreover, when comparing between AD and control cerebellum samples, we observed hypermethylation of the rDNA promoter region as well as an increase in rDNA content. In addition, we also observed increased rRNA levels in AD compared to control cerebellum. Although still considered a pathology-free brain region, there are growing findings that continue to suggest otherwise. Indeed, cerebellum from AD has been recently described as affected by the disease, presenting a unique pattern of molecular alterations. Given that we observed that increased rDNA promoter methylation did not silence rDNA gene expression, we suggest that rDNA promoter hypermethylation is playing a protective role in rDNA genomic stability and, therefore, increasing rRNA levels in AD cerebellum. (AU)

• FAPESP's process: 15/10636-5 - Effects of the NRXN1 haploinsufficiency and the treatment with risperidone in neuronal cells
• Grantee: Elizabeth Suchi Chen
• Support Opportunities: Regular Research Grants